دورية أكاديمية
The development and flux of the University of Minnesota Survivorship Program: progress, challenges, and opportunities.
| العنوان: | The development and flux of the University of Minnesota Survivorship Program: progress, challenges, and opportunities. |
|---|---|
| المؤلفون: | Rick TJ; Department of Medicine, Division of Hematology, Oncology, and Transplantation, University of Minnesota, Minneapolis, MN, USA. rickx045@umn.edu.; M Health Fairview, Minneapolis, MN, USA. rickx045@umn.edu.; Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA. rickx045@umn.edu., Lee J; M Health Fairview, Minneapolis, MN, USA.; Department of Pediatrics, Division of Hematology/Oncology, University of Minnesota, Minneapolis, MN, USA., Skendzel S; Department of Medicine, Division of Hematology, Oncology, and Transplantation, University of Minnesota, Minneapolis, MN, USA.; M Health Fairview, Minneapolis, MN, USA., Verich K; M Health Fairview, Minneapolis, MN, USA., Schempp A; Department of Pediatrics, Division of Hematology/Oncology, University of Minnesota, Minneapolis, MN, USA., Napurski C; M Health Fairview, Minneapolis, MN, USA., Kreuser H; M Health Fairview, Minneapolis, MN, USA., Turcotte L; M Health Fairview, Minneapolis, MN, USA.; Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA.; Department of Pediatrics, Division of Hematology/Oncology, University of Minnesota, Minneapolis, MN, USA., Holtan S; Department of Medicine, Division of Hematology, Oncology, and Transplantation, University of Minnesota, Minneapolis, MN, USA.; M Health Fairview, Minneapolis, MN, USA.; Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA., Sadak K; M Health Fairview, Minneapolis, MN, USA.; Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA.; Department of Pediatrics, Division of Hematology/Oncology, University of Minnesota, Minneapolis, MN, USA., Blaes A; Department of Medicine, Division of Hematology, Oncology, and Transplantation, University of Minnesota, Minneapolis, MN, USA.; M Health Fairview, Minneapolis, MN, USA.; Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA. |
| المصدر: | Journal of cancer survivorship : research and practice [J Cancer Surviv] 2024 Feb; Vol. 18 (1), pp. 42-52. Date of Electronic Publication: 2024 Jan 31. |
| نوع المنشور: | Journal Article; Review |
| اللغة: | English |
| بيانات الدورية: | Publisher: Springer Science + Business Media Country of Publication: United States NLM ID: 101307557 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1932-2267 (Electronic) Linking ISSN: 19322259 NLM ISO Abbreviation: J Cancer Surviv Subsets: MEDLINE |
| أسماء مطبوعة: | Original Publication: New York, N.Y. : Springer Science + Business Media, c2007- |
| مواضيع طبية MeSH: | Cancer Survivors*/psychology , Neoplasms*/therapy, Adult ; Child ; Humans ; Survivorship ; Survivors ; Educational Status |
| مستخلص: | For the past 30 years, the University of Minnesota's Cancer Survivorship Program has been dedicated to providing exceptional care to patients who have lived the cancer experience. Our model is consultative, risk-stratified, and oncologist-led but executed predominately by advanced practice providers. Care is personalized and serves three survivor populations: children, adults, and patients who received BMT with over 500 new patients evaluated annually. As guidelines and survivorship standards have changed, our clinical programs have evolved from a focus on survivorship care plans to supportive care. The program offers a wide range of supportive services from acupuncture to nutritional services as well as several educational programs for patients. The program has a strong research legacy, notably as the birthplace of research that led to the Children's Oncology Group Guidelines as well as advancements in cardio-oncology and frailty after bone marrow transplantation. In 2021, we hosted the first annual Survivorship Research Forum, providing the opportunity and space for experts across disciplines to exchange ideas on a broad range of survivorship topics not possible at other national cancer-related conferences. With successes and challenges, we have identified opportunities for growth as our program continues to evolve and grow in our goal to improve cancer outcomes along a wide spectrum of physical, emotional, functional, and social dimensions. IMPLICATIONS FOR CANCER SURVIVORS: The University of Minnesota Cancer Survivorship Program provides care, education, and research opportunities for patients across the cancer continuum. (© 2024. The Author(s).) |
| References: | Medicine I of, Council NR. In: Hewitt M, Greenfield S, Stovall E, editors. From cancer patient to cancer survivor: lost in transition [Internet]. Washington, DC: The National Academies Press; 2006. https://nap.nationalacademies.org/catalog/11468/from-cancer-patient-to-cancer-survivor-lost-in-transition . Hudson MM, Mertens AC, Yasui Y, Hobbie W, Chen H, Gurney JG, et al. Health status of adult long-term survivors of childhood cancer: a report from the childhood cancer survivor study. JAMA. 2003;290(12). Majhail NS, Murphy E, Laud P, Preussler JM, Denzen EM, Abetti B, et al. Randomized controlled trial of individualized treatment summary and survivorship care plans for hematopoietic cell transplantation survivors. Haematologica. 2019;104(5). THRIVE Cancer Survivorship Class Series | Cancer Survivorship Program [Internet]. [cited 2023 Jul 27]. https://survivorship.umn.edu/thrive-cancer-survivorship-class-series. Turcotte LM, Liu Q, Yasui Y, Henderson TO, Gibson TM, Leisenring W, et al. Chemotherapy and risk of subsequent malignant neoplasms in the childhood cancer survivor study cohort. J Clin Oncol [Internet]. 2019 [cited 2023 Jul 27];37(34):3310–3319. https://pubmed.ncbi.nlm.nih.gov/31622130/. Henderson TO, Fowler BW, Hamann HA, Nathan PC, Whitton J, Leisenring WM, et al. Subsequent malignant neoplasms in the Childhood Cancer Survivor Study: occurrence of cancer types in which human papillomavirus is an established etiologic risk factor. Cancer [Internet]. 2022 Jan 15 [cited 2023 Jul 27];128(2):373–82. https://pubmed.ncbi.nlm.nih.gov/34606625/. Pamukcuoglu M, Bhatia S, Weisdorf DJ, Defor TE, Ustun C, Nayar M, et al. Supportive care hematopoietic cell transplant à related toxicities and mortality in frail recipients. 2019 [cited 2023 Jul 27]: https://doi.org/10.1016/j.bbmt.2019.07.030. Blaes AH. Research contributions from the First Cancer Center Survivorship Research Forum. J Cancer Survivorship [Internet]. 2022 Feb 1 [cited 2023 Aug 24];16(1):1–3. https://link.springer.com/article/10.1007/s11764-021-01137-0. |
| فهرسة مساهمة: | Keywords: Cancer; Cancer Survivorship Program; Cancer survivorship; Long-term follow-up; Program evaluation |
| تواريخ الأحداث: | Date Created: 20240131 Date Completed: 20240215 Latest Revision: 20240524 |
| رمز التحديث: | 20240524 |
| مُعرف محوري في PubMed: | PMC10867059 |
| DOI: | 10.1007/s11764-023-01520-z |
| PMID: | 38294598 |
| قاعدة البيانات: | MEDLINE |
Find this article in full text from Springer Verlag. 
Full Text Finder | تدمد: | 1932-2267 |
|---|---|
| DOI: | 10.1007/s11764-023-01520-z |